# Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.

> **NCT04413929** · — · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 8411 (actual)

## Conditions studied

- Viral Respiratory Infection

## Interventions

- **DRUG:** Ergoferon

## Key facts

- **NCT ID:** NCT04413929
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 8411 (ACTUAL)
- **Last updated:** 2021-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04413929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04413929, "Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04413929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*